Literature DB >> 14727170

Implantable venous port-related infections in cancer patients.

Wen-Tsung Huang1, Tsai-Yun Chen, Wu-Chou Su, Chia-Jui Yen, Chao-Jung Tsao.   

Abstract

OBJECTIVES: To evaluate the characteristics of implantable venous port-related infections in patients with malignancies. PATIENTS AND METHODS: This was a 6-year study in which all the records of cancer patients who were diagnosed with port-related infections were retrospectively analyzed.
RESULTS: The analysis included 36 episodes of port-related infections. The median period from port implantation to the episode of port-related infection was 164 days (21 to 1650 days). Of the 36 episodes, 15 (42%) were polymicrobial infections, and 21 (58%) were gram-negative pathogens. If only the port-related bacteremia was taken into consideration, gram-negative bacilli and gram-positive cocci accounted for 39 and 7 pathogens of the total 53 isolated microorganisms (74% and 13%, respectively). Stenotrophomonas maltophilia and Acinetobacter baumanii were the predominant causal microorganisms. All except two infectious catheters were removed. No infection-related mortality developed.
CONCLUSIONS: Gram-negative bacilli, especially the glucose-non-fermenting pathogens, tend to be the major microorganisms that account for port-related infections, and the infections run a benign course, even those developed in septicemia.

Entities:  

Mesh:

Year:  2004        PMID: 14727170     DOI: 10.1007/s00520-003-0576-z

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  22 in total

1.  Diagnosis of venous access port-related infections.

Authors:  M C Douard; G Arlet; P Longuet; C Troje; M Rouveau; D Ponscarme; B Eurin
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

Review 2.  Infectious complications of febrile leukopenia.

Authors:  H Giamarellou; A Antoniadou
Journal:  Infect Dis Clin North Am       Date:  2001-06       Impact factor: 5.982

3.  Changes in the spectrum of organisms causing bacteremia and fungemia in immunocompromised patients due to venous access devices.

Authors:  T E Kiehn; D Armstrong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-12       Impact factor: 3.267

Review 4.  Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria.

Authors:  S H Zinner
Journal:  Clin Infect Dis       Date:  1999-09       Impact factor: 9.079

5.  Bacteremia by gram-negative bacilli in patients with hematologic malignancies. Comparison of the clinical presentation and outcome of infections by enterobacteria and non-glucose-fermenting gram-negative bacilli.

Authors:  R Martino; A Santamaría; L Muñoz; R Pericas; A Altés; G Prats; J Sierra
Journal:  Acta Haematol       Date:  1999       Impact factor: 2.195

6.  Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials.

Authors:  L S Elting; E B Rubenstein; K V Rolston; G P Bodey
Journal:  Clin Infect Dis       Date:  1997-08       Impact factor: 9.079

7.  Changing pattern of pathogens causing broviac catheter-related bacteraemias in children with cancer.

Authors:  E Castagnola; A Garaventa; C Viscoli; G Carrega; M Nantron; C Molinari; C Moroni; R Giacchino
Journal:  J Hosp Infect       Date:  1995-02       Impact factor: 3.926

8.  Comparison of infections in Hickman and implanted port catheters in adult solid tumor patients.

Authors:  D Pegues; P Axelrod; C McClarren; B L Eisenberg; J P Hoffman; F D Ottery; R D Keidan; M Boraas; J Weese
Journal:  J Surg Oncol       Date:  1992-03       Impact factor: 3.454

9.  Infectious morbidity associated with long-term use of venous access devices in patients with cancer.

Authors:  J S Groeger; A B Lucas; H T Thaler; H Friedlander-Klar; A E Brown; T E Kiehn; D Armstrong
Journal:  Ann Intern Med       Date:  1993-12-15       Impact factor: 25.391

10.  Treatment of Hickman catheter sepsis using antibiotic lock technique.

Authors:  E A Krzywda; D A Andris; C E Edmiston; E J Quebbeman
Journal:  Infect Control Hosp Epidemiol       Date:  1995-10       Impact factor: 3.254

View more
  2 in total

1.  Vancomycin flush as antibiotic prophylaxis for early catheter-related infections: a cost-effectiveness analysis.

Authors:  Nicolas Penel; Yazdan Yazdanpanah
Journal:  Support Care Cancer       Date:  2008-07-29       Impact factor: 3.603

2.  Port type is a possible risk factor for implantable venous access port-related bloodstream infections and no sign of local infection predicts the growth of gram-negative bacilli.

Authors:  Jui-Feng Hsu; Hsu-Liang Chang; Ming-Ju Tsai; Ying-Ming Tsai; Yen-Lung Lee; Pei-Huan Chen; Wen-Chieh Fan; Yu-Chung Su; Chih-Jen Yang
Journal:  World J Surg Oncol       Date:  2015-09-30       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.